The Danish Spatial Imaging Consortium
Proudly funded by
Novo Nordisk Foundation
News
12 May 2026
NNF Site Visit to DanSIC
Odense, Denmark. The Novo Nordisk Foundation visits DanSIC for an onsite engagement with the core team – covering scientific progress, administrative updates, and a tour of labs and facilities. The visit also brings together other NNF-funded research infrastructures in Odense to strengthen knowledge sharing and networking across projects.
30 April 2026
NNF Research Infrastructure Grantee Meeting
10:00-17:00 CET | Novo Nordisk Foundation, Tuborg Havnevej 19, 2900 Hellerup, Denmark.
DanSIC participates in the annual NNF Research Infrastructure Grantee Meeting, presenting progress updates and connecting with fellow NNF-funded research infrastructure teams.
20 April 2026
Odense, Denmark, May 11-14, 2027. Course fee: €650. Endorsed by ISBM and EUROD.
Register before 1 February 2027.
Jan 09 2026
We are looking for a research assistant/postdoc as a spatial bioinformatician between DanSIC and CIMP at SDU. Apply.
April 24 2025
We are excited to announce the publication of our latest study in Bone Research, titled ‘Mapping RANKL- and OPG-expressing cells in bone tissue: the bone surface cells as activators of osteoclastogenesis and promoters of the denosumab rebound effect’ Read more.
Feb 28 2025
We are now a member of the Integrated Multi-Omics in Precision Medicine (CIMP), and we look forward to continuing our strong partnership between University of Southern Denmark and Odense University Hospital to address clinical challenges and improve treatment outcomes.
Feb 27 2025
We are officially part of the national CellX infrastructure
Feb 20 2024
Authors: Bilal M El-Masri, Benedeta Leka, Fatima Mustapha, Michael Tveden Gundesen, Maja Hinge, Thomas Lund, Thomas L Andersen, Marta Diaz-delCastillo, Abbas Jafari
Oncotarget. 2024; 15: 20–26.
Published online 2024 Jan 16. doi: 10.18632/oncotarget.28548
About DanSIC
The Danish Spatial Imaging Consortium (DanSIC) is an international research infrastructure dedicated to spatial omics analysis. We were established across Southern Denmark University (Odense) and Aarhus University, Denmark, in the year 2023. We are proudly funded by the Novo Nordisk Foundation.
We aim to facilitate a better understanding and patient-tailored treatment of bone diseases, and other diseases. Our four specialized spatial and molecular imaging platforms and seven overarching state-of-the-art methodologies, bridge the gap between our detailed understanding of individual cell populations and their real-life supracellular context in patients. DanSIC collaborates with scientists from multiple disciplines and take advantage of recent advances in 2D and 3D spatial molecular imaging.
Bridging
Our Connected Network
The Danish Spatial Imaging Consortium (DanSIC) is a research infrastructure for spatial omics, established in 2023 and funded by the Novo Nordisk Foundation.
The Molecular Bone Histology Lab (MBHLab) operates under the same scientific leadership as DanSIC, specialising in advanced bone histology.
We seek to
Advance understanding in biology with spatial omics
We locate
DEPARTMENT OF FORENSIC RESEARCH
AARHUS UNIVERSITY
DEPARTMENT OF CLINICAL RESEARCH
UNIVERSITY OF SOUTHERN DENMARK
DEPARTMENT OF PATHOLOGY
ODENSE UNIVERSITY HOSPITAL
We bridge
researchers who share a common interest in analyzing cells spatially and tissues at the single-cell level.
DanSIC provides easy access to cutting-edge technologies and robust support for downstream data analysis. The platform’s partnerships extend nationally and internationally.
We enable
the design of patient-relevant translational experiments across all relevant spatial and molecular imaging ranges with our unique and worldwide collaborative network. The combination of interdisciplinary bone experts and state-of-the-art infrastructure will foster major breakthroughs in our understanding of human bone physiology and pathophysiology from tissue level and down to single cell level inpatients.
DanSIC and their national and international partners focus on the skeletal effect of aging, osteoporosis,multiple myeloma, rare genetic disorders, breast and prostate cancer metastasis, type 1 and 2 diabetes and related optimal treatment strategies. DanSIC infrastructure is also open for local DanSIC partners performing non-bone projects, and for research institutions, hospitals, incubators, and larger companies.